Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN FRANCISCO and GENEVA, Dec. 11, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutic products...
-
SAN FRANCISCO and GENEVA, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutic products...
-
SAN FRANCISCO and GENEVA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutic products...
-
SAN FRANCISCO and GENEVA, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a diversified biotechnology company focused on the development of diagnostic and...
-
Full dataset on 140 patients in mild, moderate and severe Alzheimer's disease subjects expected to be announced in December 2014 SAN FRANCISCO and GENEVA, Nov. 20, 2014 (GLOBE NEWSWIRE) --...
-
Engineered Skin substitute (ESS): Phase 1/ Early Phase 2 product candidate that has potential to be a revolutionary new treatment for severe burns ESS granted Orphan Drug designation and,...
-
SAN FRANCISCO and GENEVA, Switzerland, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a diversified biotechnology company focused on the development of diagnostic...
-
Amarantus Reports Third Quarter 2014 Financial Results and Enters Into Strategic Preferred Financing
SAN FRANCISCO and GENEVA, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology holding company focused on the development of diagnostics and therapeutics...
-
SAN FRANCISCO and GENEVA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for...
-
SAN FRANCISCO and GENEVA, Oct. 16, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics and therapeutics for...